GeneFerm Biotechnology Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 133.91 million compared to TWD 92.89 million a year ago. Net income was TWD 18.22 million compared to TWD 4.14 million a year ago. Basic earnings per share from continuing operations was TWD 0.45 compared to TWD 0.14 a year ago. Diluted earnings per share from continuing operations was TWD 0.4 compared to TWD 0.14 a year ago. For the nine months, sales was TWD 368.73 million compared to TWD 264.56 million a year ago. Net income was TWD 39.95 million compared to net loss of TWD 1.56 million a year ago. Basic earnings per share from continuing operations was TWD 1.02 compared to basic loss per share from continuing operations of TWD 0.06 a year ago. Diluted earnings per share from continuing operations was TWD 0.93 compared to diluted loss per share from continuing operations of TWD 0.06 a year ago.